# OnCo record nct05765812 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05765812/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05765812", "NCT05765812" ;
  schema:name "A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma"@en ;
  schema:description "A phase 1/2 trial of Temozolomide in glioma & glioblastoma, run by Debiopharm International SA, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05765812/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05765812> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2023-05-15" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/temozolomide/> ;
  onco:companies <https://onco.cc/companies/debiopharm/> .